OP-128 PROSTHETIC VALVE THROMBOSIS DURING PREGNANCY ASSOCIATED WITH LOW MOLECULAR WEIGHT HEPARIN USE

2012 ◽  
Vol 155 ◽  
pp. S28
Author(s):  
G. Altunbas ◽  
E.E. Gul ◽  
Z. Kaya ◽  
K. Ozdemir
Keyword(s):  
Molecular Weight ◽  
Low Molecular Weight Heparin ◽  
Prosthetic Valve ◽  
Low Molecular Weight ◽  
Prosthetic Valve Thrombosis ◽  
Valve Thrombosis

MECHANICAL HEART VALVES AND PREGNANCY

2007 ◽  
Vol 18 (4) ◽  
pp. 311-331 ◽  
Author(s):  
CYNTHIA MAXWELL ◽  
MATHEW SERMER
Keyword(s):  
Molecular Weight ◽  
Low Molecular Weight Heparin ◽  
Heart Valves ◽  
First Trimester ◽  
Mechanical Heart Valves ◽  
Low Molecular Weight ◽  
Valve Thrombosis ◽  
First Trimester Of Pregnancy ◽  
Primary Agent ◽  
In Pregnancy

Mechanical heart valves pose a particular challenge in pregnancy, as the primary agent used to prevent valve thrombosis, coumadin (warfarin), is a known teratogen. Alternatives to coumadin, such as unfractionated heparin (UFH) and low-molecular weight heparin (LMWH) are safer for the fetus, particularly during the first trimester of pregnancy, but expose the mother to potential valve failure. This review will examine these controversies and the complex literature regarding management in pregnancy.

Low-molecular-weight heparin in the prevention and treatment of thromboembolic disorders

1998 ◽  
Vol 1 (5) ◽  
pp. 166-174 ◽  
Author(s):  
Evelyn R Hermes De Santis ◽  
Betsy S Laumeister ◽  
Vidhu Bansal ◽  
Vandana Kataria ◽  
Preeti Loomba ◽  
...  
Keyword(s):  
Molecular Weight ◽  
Low Molecular Weight Heparin ◽  
Low Molecular Weight ◽  
Prevention And Treatment
Sign in / Sign up

Export Citation Format

Share Document